Scancell Holdings Plc

As of October 31, 2025, Scancell Holdings Plc carries a market capitalization of 10.22B, placing it among publicly traded companies globally. Its enterprise value stands at 10.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Scancell Holdings Plc's next confirmed earnings release is scheduled for February 4, 2027.

As of October 31, 2025, Scancell Holdings Plc has 103.78M shares outstanding.

These figures are as of October 31, 2025.

As of October 31, 2025, Scancell Holdings Plc maintains a current ratio of 0.56, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Scancell Holdings Plc's stock has declined approximately 4.71% over the past 52 weeks. The 50-day moving average sits at 95.85, while the 200-day moving average is 134.43.

As of October 31, 2025, Scancell Holdings Plc holds 857.40M in cash and equivalents against 1.62B in total debt, resulting in a net debt position of 728.80M. Total book value stands at -837.20M, with working capital of -1.05B providing operational flexibility.

Scancell Holdings Plc's most recent stock split took place on October 21, 2026 with a 10:1 split ratio.